NO124485B - - Google Patents

Download PDF

Info

Publication number: NO124485B
Authority: NO; Norway
Prior art keywords: solution; pyridyl; mol; give; cooled
Prior art date: 1968-12-30

Application number

NO5082/69A

Other languages

English (en)

Norwegian (no)

Inventor

K Doebel

N Gruenfeld

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1968-12-30

Filing date

1969-12-22

Publication date

1972-04-24

1969-12-22 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1972-04-24 Publication of NO124485B publication Critical patent/NO124485B/no

Links

150000001875 compounds Chemical class 0.000 claims description 13
238000000034 method Methods 0.000 claims description 6
125000000217 alkyl group Chemical group 0.000 claims description 4
239000002253 acid Substances 0.000 claims description 3
239000007788 liquid Substances 0.000 claims description 3
238000002360 preparation method Methods 0.000 claims description 3
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 3
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
239000001257 hydrogen Substances 0.000 claims description 2
229910052739 hydrogen Inorganic materials 0.000 claims description 2
229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
239000011707 mineral Substances 0.000 claims description 2
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 57
239000000243 solution Substances 0.000 description 44
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 14
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
239000000725 suspension Substances 0.000 description 12
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 11
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
239000012299 nitrogen atmosphere Substances 0.000 description 7
ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 6
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
239000004202 carbamide Substances 0.000 description 6
235000013877 carbamide Nutrition 0.000 description 6
-1 ethylene acetal Chemical class 0.000 description 6
239000012948 isocyanate Substances 0.000 description 6
239000000203 mixture Substances 0.000 description 6
239000000047 product Substances 0.000 description 6
238000010992 reflux Methods 0.000 description 6
239000007858 starting material Substances 0.000 description 6
239000002904 solvent Substances 0.000 description 5
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
238000001914 filtration Methods 0.000 description 4
238000000746 purification Methods 0.000 description 4
229910052938 sodium sulfate Inorganic materials 0.000 description 4
235000011152 sodium sulphate Nutrition 0.000 description 4
GDERTSDYCOIBFT-UHFFFAOYSA-N 3-pyridin-2-yl-1H-imidazol-2-one Chemical class N1=C(C=CC=C1)N1C(NC=C1)=O GDERTSDYCOIBFT-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 3
150000001241 acetals Chemical class 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
238000009833 condensation Methods 0.000 description 3
230000005494 condensation Effects 0.000 description 3
238000000354 decomposition reaction Methods 0.000 description 3
239000000706 filtrate Substances 0.000 description 3
239000000463 material Substances 0.000 description 3
239000012044 organic layer Substances 0.000 description 3
239000007787 solid Substances 0.000 description 3
RCSHCHZJZUXQGW-UHFFFAOYSA-N 1,1-diethoxy-2-isocyanatoethane Chemical compound CCOC(OCC)CN=C=O RCSHCHZJZUXQGW-UHFFFAOYSA-N 0.000 description 2
LYIIBVSRGJSHAV-UHFFFAOYSA-N 2-aminoacetaldehyde Chemical compound NCC=O LYIIBVSRGJSHAV-UHFFFAOYSA-N 0.000 description 2
SHVVSKCXWMEDRW-UHFFFAOYSA-N 3-isocyanatopyridine Chemical compound O=C=NC1=CC=CN=C1 SHVVSKCXWMEDRW-UHFFFAOYSA-N 0.000 description 2
239000005977 Ethylene Substances 0.000 description 2
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
LQTQQZHJHDXTTC-UHFFFAOYSA-N N1=C(C=CC=C1)NC(=O)NCC(OCC)OCC Chemical compound N1=C(C=CC=C1)NC(=O)NCC(OCC)OCC LQTQQZHJHDXTTC-UHFFFAOYSA-N 0.000 description 2
YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
238000001816 cooling Methods 0.000 description 2
239000002552 dosage form Substances 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
239000000284 extract Substances 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
150000007524 organic acids Chemical class 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
QPMCUNAXNMSGTK-UHFFFAOYSA-N 2-aminopropanal Chemical compound CC(N)C=O QPMCUNAXNMSGTK-UHFFFAOYSA-N 0.000 description 1
PPHVFMDULQHSTJ-UHFFFAOYSA-N 3-(azidomethyl)pyridine Chemical compound [N-]=[N+]=NCC1=CC=CN=C1 PPHVFMDULQHSTJ-UHFFFAOYSA-N 0.000 description 1
WPWVYEAGXFCKEJ-UHFFFAOYSA-N 3-pyridin-3-yl-1h-imidazol-2-one Chemical compound O=C1NC=CN1C1=CC=CN=C1 WPWVYEAGXFCKEJ-UHFFFAOYSA-N 0.000 description 1
125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
WVUNMPYWFIZBLT-UHFFFAOYSA-N 4-pyridin-2-ylimidazol-2-one Chemical class O=C1N=CC(C=2N=CC=CC=2)=N1 WVUNMPYWFIZBLT-UHFFFAOYSA-N 0.000 description 1
239000004243 E-number Substances 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
WZELXJBMMZFDDU-UHFFFAOYSA-N Imidazol-2-one Chemical group O=C1N=CC=N1 WZELXJBMMZFDDU-UHFFFAOYSA-N 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
206010037660 Pyrexia Diseases 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
150000003927 aminopyridines Chemical class 0.000 description 1
230000000202 analgesic effect Effects 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
230000001754 anti-pyretic effect Effects 0.000 description 1
239000002775 capsule Substances 0.000 description 1
239000003610 charcoal Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000002026 chloroform extract Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
238000009472 formulation Methods 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
150000002430 hydrocarbons Chemical group 0.000 description 1
239000012442 inert solvent Substances 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
239000002198 insoluble material Substances 0.000 description 1
150000002513 isocyanates Chemical class 0.000 description 1
JMFJXZKGJLFGEJ-UHFFFAOYSA-N isocyanic acid;pyridine Chemical compound N=C=O.C1=CC=NC=C1 JMFJXZKGJLFGEJ-UHFFFAOYSA-N 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
238000002156 mixing Methods 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
239000008024 pharmaceutical diluent Substances 0.000 description 1
239000000843 powder Substances 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000004076 pyridyl group Chemical group 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
238000007363 ring formation reaction Methods 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000000859 sublimation Methods 0.000 description 1
230000008022 sublimation Effects 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000003826 tablet Substances 0.000 description 1
150000003672 ureas Chemical class 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47J—KITCHEN EQUIPMENT; COFFEE MILLS; SPICE MILLS; APPARATUS FOR MAKING BEVERAGES
- A47J17/00—Household peeling, stringing, or paring implements or machines
- A47J17/08—Asparagus peelers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO5082/69A 1968-12-30 1969-12-22 NO124485B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US78800768A	1968-12-30	1968-12-30

Publications (1)

Publication Number	Publication Date
NO124485B true NO124485B (sv)	1972-04-24

Family

ID=25143160

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO5082/69A NO124485B (sv)	1968-12-30	1969-12-22

Country Status (11)

Country	Link
US (1)	US3542798A (sv)
AT (1)	AT289106B (sv)
BE (1)	BE743802A (sv)
CH (1)	CH517758A (sv)
DE (1)	DE1965320A1 (sv)
ES (1)	ES374976A1 (sv)
FR (1)	FR2027337B1 (sv)
GB (1)	GB1301110A (sv)
IL (1)	IL33624A (sv)
NL (1)	NL6919211A (sv)
NO (1)	NO124485B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4604127A (en) *	1984-07-17	1986-08-05	Eli Lilly And Company	Herbicidal pyridazinylimidazolidinone compounds
US4600430A (en) *	1985-02-22	1986-07-15	Eli Lilly And Company	Pyridinylimidazolidinone compounds
US4911753A (en) *	1987-01-21	1990-03-27	American Cyanamid Company	Herbicidal 2-(2-imidazolin-2-yl)fluoroalkoxy-, alkenyloxy-, and alkynyloxypyridines and quinolines
BR112013009823A2 (pt)	2010-10-22	2016-07-05	Bayer Ip Gmbh	novos compostos heterocíclicos como pesticidas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3236853A (en) *	1962-07-19	1966-02-22	Hoechst Ag	Triazolidines and process for preparing them

1968
- 1968-12-30 US US788007A patent/US3542798A/en not_active Expired - Lifetime
1969
- 1969-12-22 NO NO5082/69A patent/NO124485B/no unknown
- 1969-12-22 NL NL6919211A patent/NL6919211A/xx unknown
- 1969-12-24 CH CH1923769A patent/CH517758A/de not_active IP Right Cessation
- 1969-12-29 IL IL33624A patent/IL33624A/en unknown
- 1969-12-29 ES ES374976A patent/ES374976A1/es not_active Expired
- 1969-12-29 FR FR696945210A patent/FR2027337B1/fr not_active Expired
- 1969-12-29 AT AT1206069A patent/AT289106B/de not_active IP Right Cessation
- 1969-12-29 GB GB63061/69A patent/GB1301110A/en not_active Expired
- 1969-12-29 DE DE19691965320 patent/DE1965320A1/de active Pending
- 1969-12-29 BE BE743802D patent/BE743802A/xx unknown

Also Published As

Publication number	Publication date
FR2027337B1 (sv)	1973-04-06
US3542798A (en)	1970-11-24
GB1301110A (en)	1972-12-29
FR2027337A1 (sv)	1970-09-25
IL33624A0 (en)	1970-02-19
IL33624A (en)	1972-08-30
DE1965320A1 (de)	1970-07-16
AT289106B (de)	1971-04-13
CH517758A (de)	1972-01-15
ES374976A1 (es)	1972-02-16
NL6919211A (sv)	1970-07-02
BE743802A (sv)	1970-06-29

Publication	Publication Date	Title
AU737552B2 (en)	2001-08-23	Oxadiazoles, processes for preparing them and their use as pharmaceutical compositions
EP0861236B1 (de)	2002-02-13	Cyclische und heterocyclische n-substituierte alpha-iminohydroxam- und carbonsäuren
CN105518005A (zh)	2016-04-20	作为rock抑制剂的三环吡啶-甲酰胺衍生物
AU716435B2 (en)	2000-02-24	Novel indole-2,3-dione-3-oxime derivatives
JP3281320B2 (ja)	2002-05-13	神経伝達物質放出増強薬としての新規な非環式アミド類
EP0181136B1 (en)	1992-03-25	Oxindole antiinflammatory agents
EP0873325B1 (en)	2003-03-12	Process for producing guanidine derivatives, intermediates therefor and their production
Bourdais et al.	1980	Polycyclic azines. III. Synthesis of 3‐aminoimidazo [1, 5‐a] pyridine derivatives by cyclodesulfurization of N′‐Substituted‐N‐(2‐pyridylmethyl) thioureas with dicyclohexylcarbodiimide
NO812484L (no)	1982-01-22	Fremgangsmaate ved fremstilling av antiinflammatoriske 4,5-diaryl-alfa-polyfluoralkyl-1h-imidazol-2-methanaminer
EP0173520A2 (en)	1986-03-05	Tricyclic oxindole antiinflammatory agents
JPH05194359A (ja)	1993-08-03	新規尿素誘導体、その製法と治療用途
JPS5951537B2 (ja)	1984-12-14	新規α−アミノオキシカルボン酸ヒドラジド誘導体の製造法
NO124485B (sv)	1972-04-24
Galat	1951	Synthesis of papaverine and some related compounds
JP3413632B2 (ja)	2003-06-03	グアニジン誘導体の製造方法
US4192944A (en)	1980-03-11	Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents
CA2137443A1 (en)	1995-06-07	Thienothiazinderivatives, process for their preparation and their use
JP3042915B2 (ja)	2000-05-22	３−（１ｈ−インダゾール−３−イル）−４−ピリジンアミンおよびその製造法
NO133670B (sv)	1976-03-01
US4287211A (en)	1981-09-01	Derivatives of phenylethylamines, processes for their preparation and related pharmaceutical compositions
SU980624A3 (ru)	1982-12-07	Способ получени имидазо (2,1-в) хиназолинов или их солей
PT88244B (pt)	1995-03-01	Processo para a preparacao de derivados de tetrazole antagonistas de leucotrienos
KR920006784B1 (ko)	1992-08-17	소염성 1-헤테로아릴-옥신돌-3-카복스아미드
CA2032973A1 (en)	1991-06-28	Aminopyridinylmethanols and aminomethylpyridinamines and related compounds, a process for their preparation and their use as medicaments
US4003901A (en)	1977-01-18	Nitrosourea derivative